Side-by-side financials for CNTB and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNTB | LLY |
|---|---|---|
| Market cap | - | $1.093 T |
| US-listed rank | - | #11 |
| Revenue (latest FY) | $64.00K | $65.18B |
| Net income (latest FY) | -$55.48M | $20.64B |
| Net margin | -86687.5% | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 180 | 989 |
In their latest fiscal years, Connect Biopharma Holdings Ltd reported $64.00K in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Connect Biopharma Holdings Ltd and ELI LILLY & Co, or browse the full rankings.